NanoViricides
NNVC
NanoViricides (NNVC) earnings history
Most recent quarter
- Fiscal period
- Q3 2024
- Period end
- Mar 31, 2024
- EPS actual
- −$0.51
- EPS estimate
- −$0.15
- EPS surprise
- −240.00%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- May 15, 2024
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2024 | May 15, 2024 | −$0.15 | −$0.51 | −240.00% | $0.00 | SEC |
| Q2 2024 | Feb 14, 2024 | −$0.19 | −$0.18 | +5.26% | $0.00 | SEC |
| Q1 2024 | Nov 14, 2023 | −$0.17 | −$0.17 | +0.00% | $0.00 | SEC |
| Q2 2023 | Feb 14, 2023 | −$0.16 | −$0.15 | +6.25% | $0.00 | SEC |
| Q1 2023 | Nov 14, 2022 | −$0.14 | −$0.14 | +0.00% | $0.00 | — |
| Q4 2022 | Oct 13, 2022 | −$0.23 | −$0.15 | +34.78% | $0.00 | — |
| Q2 2022 | Feb 14, 2022 | $0.00 | −$0.17 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did NanoViricides (NNVC) last report earnings?
NanoViricides last reported on May 15, 2024, covering fiscal Q3 2024.
Did NNVC beat earnings estimates?
No. NanoViricides reported EPS of −$0.51 for Q3 2024 against a −$0.15 estimate — a 240.00% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.